The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Aren't we also listed on NEX and if so does this protect our ISA's for a little longer?
Remy selling some of his ORR stock.
Wonder what he'll be doing with the money? Hopefully adding it here.
Crazy that we're down to a £15M MCAP. Lower than this time last year before we knew what we had with CE and now with sulphides at Muswema, well funded for 2020 and ability to produce at Kalaba.
I'm trying to build what I can in time for the upturn here to take advantage of the current market madness.
What a day, when a suspended stock is the best performer in your portfolio!
Because your research showed that ARCM met your investment criteria I imagine?
NvS, Remy and others excellent pedigree
Best results from Africa in years
Ever increasing copper assets
Majors on site
Funded well into 2020
Can self fund from Kalaba plant
This one demands patience as a 12 / 18 month plan lies ahead perhaps, or the killer RNS could drop tomorrow.
I know it gets difficult at times, but I think you made a good choice personally.
Happy to wait it out here rather than chasing rainbows.
I trust that patience will be rewarded with this one.
Reme suggested CASA should be gone within the next couple of months.
Scoping study on it's way.
More sulphide news from Muswema.
Well funded
Holding and adding when possible.
I think FQM / Sentinel would be more interested in sulphides which I believe would be more aligned to their processes.
This is why this weeks Muswema suphides news is such a big deal IMO and could turn out to absolutely massive.
Have seen the new ARCM presentation? It refers to "massive sulphide mineralisation" at Muswema!
So the oxides at Cheyeza could be processed at Kalaba (remember scoping study for this is on the way), OR Ivanhoes kamoa kakula mines who I think process oxides.
Opinions welcome, but this is my take on this as it stands.
I find it interesting that significant sulphides are announced in an RNS on day 1 of Indaba, which obviously now allows discussion of the findings with potentially interested parties over there. Very convenient timing!
Nice 2M / £52K buy at the end today. Graham you topped up again?